Y-mAbs Therapeutics
YMAB
#7272
Rank
NZ$0.64 B
Marketcap
$14.38
Share price
-2.05%
Change (1 day)
21.95%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -NZ$46.2 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are NZ$84.55 Million. In 2023 the company made an earning of -NZ$45.51 Million, an increase over its 2022 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$46.2 Million1.52%
2023 -NZ$45.51 Million-72.92%
2022 -NZ$0.17 Billion77.47%
2021 -NZ$94.7 Million-55.46%
2020 -NZ$0.22 Billion44.49%
2019 -NZ$0.15 Billion92.01%
2018 -NZ$76.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 373.42%๐Ÿ‡บ๐Ÿ‡ธ USA